De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

KKR Toekomstige groei

Future criteriumcontroles 2/6

De omzet van KKR zal naar verwachting dalen met 32.5% per jaar, terwijl de jaarlijkse winst naar verwachting zal groeien met 18.6% per jaar. De winst per aandeel zal naar verwachting groeien met 19.1% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 13.4% zijn.

Belangrijke informatie

18.6%

Groei van de winst

19.1%

Groei van de winst per aandeel

Capital Markets winstgroei	14.8%
Inkomstengroei	-32.5%
Toekomstig rendement op eigen vermogen	13.4%
Dekking van analisten	Good
Laatst bijgewerkt	01 Oct 2024

Recente toekomstige groei-updates

Recent updates

Winst- en omzetgroeiprognoses

NYSE:KKR - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	11,318	6,848	7,288	N/A	4
12/31/2025	9,645	5,477	6,142	N/A	5
12/31/2024	7,324	4,154	2,340	N/A	5
6/30/2024	26,611	3,863	7,873	7,963	N/A
3/31/2024	26,064	4,040	1,864	1,967	N/A
12/31/2023	18,664	3,681	-1,602	-1,494	N/A
9/30/2023	15,280	2,761	-3,354	-3,248	N/A
6/30/2023	12,049	1,321	-6,817	-6,705	N/A
3/31/2023	6,136	-258	-8,225	-8,129	N/A
12/31/2022	5,515	-591	-5,364	-5,279	N/A
9/30/2022	7,142	-204	-8,328	-8,250	N/A
6/30/2022	12,087	895	-9,103	-9,016	N/A
3/31/2022	19,983	2,907	-6,273	-6,187	N/A
12/31/2021	24,821	4,627	-7,279	-7,177	N/A
9/30/2021	26,832	5,539	-5,489	-5,365	N/A
6/30/2021	24,426	5,455	-4,650	-4,523	N/A
3/31/2021	20,785	4,876	-4,756	-4,620	N/A
12/31/2020	8,510	1,943	-6,107	-5,954	N/A
9/30/2020	4,716	973	-6,472	-6,317	N/A
6/30/2020	1,308	166	-5,444	-5,306	N/A
3/31/2020	743	-18	-7,478	-7,245	N/A
12/31/2019	8,077	1,972	-5,890	-5,682	N/A
9/30/2019	4,733	1,064	-6,078	-5,879	N/A
6/30/2019	5,683	1,463	-6,387	-6,182	N/A
3/31/2019	5,642	1,629	-5,409	-5,293	N/A
12/31/2018	4,199	1,101	-7,712	-7,606	N/A
9/30/2018	6,476	1,660	-6,284	-6,188	N/A
6/30/2018	5,452	1,174	-6,102	-6,008	N/A
3/31/2018	4,681	899	N/A	-4,539	N/A
12/31/2017	4,999	985	N/A	-3,532	N/A
9/30/2017	4,658	990	N/A	-3,591	N/A
6/30/2017	5,255	1,188	N/A	-2,433	N/A
3/31/2017	4,476	876	N/A	-1,974	N/A
12/31/2016	2,589	287	N/A	-1,441	N/A
9/30/2016	3,546	148	N/A	-1,903	N/A
6/30/2016	1,100	-394	N/A	-1,805	N/A
3/31/2016	4,289	-112	N/A	-1,297	N/A
12/31/2015	7,213	488	N/A	385	N/A
9/30/2015	6,522	456	N/A	1,703	N/A
6/30/2015	8,876	736	N/A	621	N/A
3/31/2015	7,630	538	N/A	3,335	N/A
12/31/2014	7,655	478	N/A	1,489	N/A
9/30/2014	10,422	756	N/A	2,300	N/A
6/30/2014	11,678	871	N/A	2,106	N/A
3/31/2014	9,611	708	N/A	164	N/A
12/31/2013	9,659	691	N/A	2,578	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei KKR ( 18.6% per jaar) ligt boven de spaarquote ( 2.5% ).

Winst versus markt: De winst van KKR ( 18.6% per jaar) zal naar verwachting sneller groeien dan de US markt ( 15.2% per jaar).

Hoge groeiwinsten: De winst van KKR zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van KKR zal naar verwachting de komende 3 jaar dalen ( -32.5% per jaar).

Hoge groei-inkomsten: De omzet van KKR zal naar verwachting de komende 3 jaar dalen ( -32.5% per jaar).

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen KKR zal naar verwachting over 3 jaar laag zijn ( 13.4 %).

KKR Toekomstige groei

Future criteriumcontroles 2/6

Belangrijke informatie

Recente toekomstige groei-updates

Price target increased by 8.6% to US$132

Recent updates

KKR Reportedly to Weigh Takeover Bid for ASMPT

Brookfield Reportedly Eyes Singapore Post

Thoma Bravo, L.P. completed the acquisition of Darktrace plc (LSE:DARK) from KKR Dark Aggregator, Summit partners.

Leonard Green & Partners, L.P. entered into an agreement to acquire GeoStabilization International LLC from KKR Americas Fund XII LP, a fund managed by KKR & Co. Inc. (NYSE:KKR).

Nomura Holdings and Mizuho Financial Group Reportedly Leading Bidders for Avendus Capital

Earnings Tell The Story For KKR & Co. Inc. (NYSE:KKR)

Impilo AB and KKR Health Care Strategic Growth Fund II SCSp managed by KKR & Co. Inc. (NYSE:KKR) completed the acquisition of an unknown minority stake in Immedica Pharma from Impilo AB.

Nomura Reportedly Enters the Race to Acquire Avendus

Alkem Reportedly Joins $3 Billion Race for JB Chem as Torrent Pauses Talks

Carlyle, Mizuho & Premji Invest Reportedly Aim for Avendus

KKR & Co. Inc. (NYSE:KKR) and Mirastar Real Estate Investment Management Limited acquired Portfolio of Five Prime Logistics assets from Peel Logistics Management Limited.

KKR's Trillion-Dollar Playbook: How Shareholders Could Win Big

KKR & Co. Inc. (NYSE:KKR) acquired Kent Valley industrial building in Auburn from Blackstone Real Estate Advisors L.P for $58.4 million.

KKR Reportedly in Talks to Buy The Parking Spot in $1.4 Billion Deal

KKR, TPG Capital, Apax Partners and Other PE Firms Reportedly Eye Purchase of Sahajanand Medical Technologies

EQT Private Capital Asia agreed to acquire PropertyGuru Group Limited (NYSE:PGRU) from TPG Capital, L.P., KKR & Co. Inc. (NYSE:KKR), REA Group Limited (ASX:REA) and others for $1 billion.

KKR-Led Consortium Reportedly Starts Sale Process for Around $3.0 Billion Philippines Hospital Business

Inter Infrastructure Capital a fund managed by IKANO Fund Management SA acquired 12.25% stake in Q-Park N.V. from company's existing shareholders and KKR Global Infrastructure Investors II LP a fund managed by KKR & Co. Inc. (NYSE:KKR).

Torrent Pharma Reportedly is Said to Seek Raising $3 Billion for KKR's Stake in JB Chemicals

KKR European Fund VI, a fund managed by KKR & Co. Inc. (NYSE:KKR) entered into an agreement to an additional 50% stake in FGS Global Inc from WPP plc (LSE:WPP) for approximately $780 million.

KKR European Fund VI, a fund managed by KKR & Co. Inc. (NYSE:KKR) entered into an agreement to an additional 50% stake in FGS Global Inc from WPP plc (LSE:WPP) for approximately $780 million.

Second quarter dividend of US$0.17 announced

Price target increased by 8.6% to US$132

Second quarter 2024 earnings released: EPS: US$0.75 (vs US$0.98 in 2Q 2023)

Now 22% overvalued after recent price rise

KKR & Co. Inc. Declares Dividend for the Second Quarter of 2024, Payable on August 27, 2024

Torrent Pharmaceuticals Reportedly in Talks to Acquire KKR’s Stake in JB Chemicals

General Atlantic, Other PE Funds Reportedly in Talks for Majority Stake in AIMS

KKR North America Fund XIII SCSp managed by KKR & Co. Inc. (NYSE:KKR) and Dragoneer Investment Group, LLC entered into a definitive agreement to acquire Instructure Holdings, Inc. from Thoma Bravo, L.P. and others for $3.6 billion.

A joint venture between T-Mobile US, Inc. (NasdaqGS:TMUS) and KKR & Co. Inc. (NYSE:KKR) entered into a definitive agreement to acquire MetroNet Holdings, LLC from Oak Hill Capital Management, LLC and the Cinelli family.

KKR & Co. Inc. (NYSE:KKR) along with Tower Bridge Infrastructure Partners LP managed by Global Infrastructure Management, LLC completed the acquisition of 40.86222% stake in Vantage Towers AG (DB:VTWR) from Vodafone GmbH.

KKR & Co. Inc. (NYSE:KKR) along with Tower Bridge Infrastructure Partners LP managed by Global Infrastructure Management, LLC completed the acquisition of 40.86222% stake in Vantage Towers AG (DB:VTWR) from Vodafone GmbH.

KKR Reportedly Mulls Options for Stake in Biotage

KKR Reportedly Considers $3 Billion Sale of KITO Crosby

KKR & Co. Inc. to Report Q2, 2024 Results on Jul 31, 2024

KKR Reportedly Considers Reviving Multibillion-Dollar Sale of Goodpack

Francisco, KKR Reportedly to Consider Takeover of Instructure

KKR Asian Fund IV and KKR & Co. Inc. (NYSE:KKR) agreed to acquire unknown controlling stake in Baby Memorial Hospital Limited.

KKR: Asset Growth Justifies Its Strong Rally

Carlyle, KKR Reportedly Shortlisted to Bid for Discover's US Student Loan Portfolio

Renesas Electronics Corporation (TSE:6723) completed the acquisition of acquire Transphorm, Inc. (NasdaqCM:TGAN) from KKR & Co. Inc. (NYSE:KKR), KKR Phorm Investors L.P., KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc. and KKR Phorm Investors GP LLC.

KKR: Overvalued Due To Rapid Multiple Expansion Despite S&P 500 Entrance

KKR Reportedly Taps Morgan Stanley for Loscam Play

Ten Suitors Reportedly in Race for Loscam

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven